nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—CYP1A1—chronic obstructive pulmonary disease	0.227	0.509	CbGaD
Rabeprazole—CYP1A2—chronic obstructive pulmonary disease	0.219	0.491	CbGaD
Rabeprazole—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.034	0.1	CbGbCtD
Rabeprazole—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.034	0.1	CbGbCtD
Rabeprazole—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0283	0.0835	CbGbCtD
Rabeprazole—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0283	0.0835	CbGbCtD
Rabeprazole—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0267	0.0788	CbGbCtD
Rabeprazole—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0258	0.0763	CbGbCtD
Rabeprazole—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0258	0.0763	CbGbCtD
Rabeprazole—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.023	0.068	CbGbCtD
Rabeprazole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0217	0.0641	CbGbCtD
Rabeprazole—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0214	0.0633	CbGbCtD
Rabeprazole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0146	0.0433	CbGbCtD
Rabeprazole—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0143	0.0422	CbGbCtD
Rabeprazole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.014	0.0413	CbGbCtD
Rabeprazole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0125	0.0368	CbGbCtD
Rabeprazole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00731	0.0216	CbGbCtD
Rabeprazole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0069	0.0204	CbGbCtD
Rabeprazole—Pantoprazole—CYP1A2—chronic obstructive pulmonary disease	0.000767	0.239	CrCbGaD
Rabeprazole—Omeprazole—CYP1A1—chronic obstructive pulmonary disease	0.000649	0.202	CrCbGaD
Rabeprazole—Omeprazole—CYP1A2—chronic obstructive pulmonary disease	0.000626	0.195	CrCbGaD
Rabeprazole—Lansoprazole—CYP1A1—chronic obstructive pulmonary disease	0.000593	0.185	CrCbGaD
Rabeprazole—Lansoprazole—CYP1A2—chronic obstructive pulmonary disease	0.000572	0.178	CrCbGaD
Rabeprazole—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000134	0.00224	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000131	0.0022	CbGpPWpGaD
Rabeprazole—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000131	0.00218	CbGpPWpGaD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000131	0.00218	CbGpPWpGaD
Rabeprazole—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.00218	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000127	0.00212	CbGpPWpGaD
Rabeprazole—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000125	0.0021	CbGpPWpGaD
Rabeprazole—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000125	0.00209	CbGpPWpGaD
Rabeprazole—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000818	CcSEcCtD
Rabeprazole—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000818	CcSEcCtD
Rabeprazole—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.000817	CcSEcCtD
Rabeprazole—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000124	0.000817	CcSEcCtD
Rabeprazole—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000815	CcSEcCtD
Rabeprazole—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.000814	CcSEcCtD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000124	0.00207	CbGpPWpGaD
Rabeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000124	0.00207	CbGpPWpGaD
Rabeprazole—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000124	0.000811	CcSEcCtD
Rabeprazole—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000809	CcSEcCtD
Rabeprazole—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.000808	CcSEcCtD
Rabeprazole—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000807	CcSEcCtD
Rabeprazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.00205	CbGpPWpGaD
Rabeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.00204	CbGpPWpGaD
Rabeprazole—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000801	CcSEcCtD
Rabeprazole—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000801	CcSEcCtD
Rabeprazole—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.000801	CcSEcCtD
Rabeprazole—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000122	0.000801	CcSEcCtD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000122	0.00203	CbGpPWpGaD
Rabeprazole—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.0008	CcSEcCtD
Rabeprazole—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000799	CcSEcCtD
Rabeprazole—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000789	CcSEcCtD
Rabeprazole—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000789	CcSEcCtD
Rabeprazole—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000789	CcSEcCtD
Rabeprazole—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00012	0.000788	CcSEcCtD
Rabeprazole—ABCG2—HIF-2-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.00012	0.002	CbGpPWpGaD
Rabeprazole—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000786	CcSEcCtD
Rabeprazole—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000119	0.000784	CcSEcCtD
Rabeprazole—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000119	0.000784	CcSEcCtD
Rabeprazole—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000119	0.000784	CcSEcCtD
Rabeprazole—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.000781	CcSEcCtD
Rabeprazole—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000119	0.000781	CcSEcCtD
Rabeprazole—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000779	CcSEcCtD
Rabeprazole—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000118	0.000775	CcSEcCtD
Rabeprazole—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000771	CcSEcCtD
Rabeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.00196	CbGpPWpGaD
Rabeprazole—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00077	CcSEcCtD
Rabeprazole—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000768	CcSEcCtD
Rabeprazole—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000768	CcSEcCtD
Rabeprazole—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000117	0.00195	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000116	0.00193	CbGpPWpGaD
Rabeprazole—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000756	CcSEcCtD
Rabeprazole—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000756	CcSEcCtD
Rabeprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.0019	CbGpPWpGaD
Rabeprazole—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000114	0.000748	CcSEcCtD
Rabeprazole—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.000748	CcSEcCtD
Rabeprazole—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000748	CcSEcCtD
Rabeprazole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000113	0.000744	CcSEcCtD
Rabeprazole—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000744	CcSEcCtD
Rabeprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.00189	CbGpPWpGaD
Rabeprazole—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000741	CcSEcCtD
Rabeprazole—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.00188	CbGpPWpGaD
Rabeprazole—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000738	CcSEcCtD
Rabeprazole—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000737	CcSEcCtD
Rabeprazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00186	CbGpPWpGaD
Rabeprazole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000111	0.000731	CcSEcCtD
Rabeprazole—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000731	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000111	0.00073	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000111	0.00073	CcSEcCtD
Rabeprazole—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00011	0.000724	CcSEcCtD
Rabeprazole—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.000724	CcSEcCtD
Rabeprazole—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000721	CcSEcCtD
Rabeprazole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00011	0.00072	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000715	CcSEcCtD
Rabeprazole—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.000714	CcSEcCtD
Rabeprazole—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000109	0.000714	CcSEcCtD
Rabeprazole—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000712	CcSEcCtD
Rabeprazole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000712	CcSEcCtD
Rabeprazole—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000108	0.000709	CcSEcCtD
Rabeprazole—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000706	CcSEcCtD
Rabeprazole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000705	CcSEcCtD
Rabeprazole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000705	CcSEcCtD
Rabeprazole—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000107	0.000704	CcSEcCtD
Rabeprazole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000107	0.000702	CcSEcCtD
Rabeprazole—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000697	CcSEcCtD
Rabeprazole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000106	0.000696	CcSEcCtD
Rabeprazole—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000694	CcSEcCtD
Rabeprazole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000105	0.00069	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000689	CcSEcCtD
Rabeprazole—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000685	CcSEcCtD
Rabeprazole—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000685	CcSEcCtD
Rabeprazole—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000685	CcSEcCtD
Rabeprazole—Pain—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000685	CcSEcCtD
Rabeprazole—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00174	CbGpPWpGaD
Rabeprazole—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.000684	CcSEcCtD
Rabeprazole—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000682	CcSEcCtD
Rabeprazole—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000682	CcSEcCtD
Rabeprazole—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000679	CcSEcCtD
Rabeprazole—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000674	CcSEcCtD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000103	0.00171	CbGpPWpGaD
Rabeprazole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000672	CcSEcCtD
Rabeprazole—Pain—Montelukast—chronic obstructive pulmonary disease	0.000102	0.000671	CcSEcCtD
Rabeprazole—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.00067	CcSEcCtD
Rabeprazole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000102	0.000669	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000666	CcSEcCtD
Rabeprazole—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000666	CcSEcCtD
Rabeprazole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000666	CcSEcCtD
Rabeprazole—CYP1A1—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000101	0.00169	CbGpPWpGaD
Rabeprazole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000101	0.000663	CcSEcCtD
Rabeprazole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000101	0.000663	CcSEcCtD
Rabeprazole—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000661	CcSEcCtD
Rabeprazole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.0001	0.00066	CcSEcCtD
Rabeprazole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.0001	0.00066	CcSEcCtD
Rabeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.0001	0.00168	CbGpPWpGaD
Rabeprazole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0001	0.000659	CcSEcCtD
Rabeprazole—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.000657	CcSEcCtD
Rabeprazole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	9.99e-05	0.000656	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	9.97e-05	0.000655	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	9.97e-05	0.000655	CcSEcCtD
Rabeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	9.9e-05	0.00165	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.87e-05	0.00165	CbGpPWpGaD
Rabeprazole—Constipation—Salbutamol—chronic obstructive pulmonary disease	9.84e-05	0.000647	CcSEcCtD
Rabeprazole—Pain—Salbutamol—chronic obstructive pulmonary disease	9.84e-05	0.000647	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	9.76e-05	0.000641	CcSEcCtD
Rabeprazole—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.76e-05	0.000641	CcSEcCtD
Rabeprazole—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	9.76e-05	0.000641	CcSEcCtD
Rabeprazole—Urticaria—Formoterol—chronic obstructive pulmonary disease	9.68e-05	0.000636	CcSEcCtD
Rabeprazole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	9.68e-05	0.000636	CcSEcCtD
Rabeprazole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	9.64e-05	0.000633	CcSEcCtD
Rabeprazole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	9.64e-05	0.000633	CcSEcCtD
Rabeprazole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	9.64e-05	0.000633	CcSEcCtD
Rabeprazole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	9.64e-05	0.000633	CcSEcCtD
Rabeprazole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	9.6e-05	0.000631	CcSEcCtD
Rabeprazole—Rash—Tiotropium—chronic obstructive pulmonary disease	9.52e-05	0.000626	CcSEcCtD
Rabeprazole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	9.51e-05	0.000625	CcSEcCtD
Rabeprazole—Nausea—Aminophylline—chronic obstructive pulmonary disease	9.51e-05	0.000625	CcSEcCtD
Rabeprazole—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	9.5e-05	0.00159	CbGpPWpGaD
Rabeprazole—Urticaria—Montelukast—chronic obstructive pulmonary disease	9.49e-05	0.000623	CcSEcCtD
Rabeprazole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	9.49e-05	0.000623	CcSEcCtD
Rabeprazole—Headache—Tiotropium—chronic obstructive pulmonary disease	9.46e-05	0.000622	CcSEcCtD
Rabeprazole—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	9.46e-05	0.000621	CcSEcCtD
Rabeprazole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	9.44e-05	0.00062	CcSEcCtD
Rabeprazole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	9.44e-05	0.00062	CcSEcCtD
Rabeprazole—Face oedema—Prednisone—chronic obstructive pulmonary disease	9.42e-05	0.000619	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	9.41e-05	0.000618	CcSEcCtD
Rabeprazole—ABCG2—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	9.28e-05	0.00155	CbGpPWpGaD
Rabeprazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.24e-05	0.00154	CbGpPWpGaD
Rabeprazole—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	9.21e-05	0.00154	CbGpPWpGaD
Rabeprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	9.16e-05	0.00153	CbGpPWpGaD
Rabeprazole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	9.14e-05	0.000601	CcSEcCtD
Rabeprazole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	9.1e-05	0.000598	CcSEcCtD
Rabeprazole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	9.1e-05	0.000598	CcSEcCtD
Rabeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9e-05	0.0015	CbGpPWpGaD
Rabeprazole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	8.98e-05	0.00059	CcSEcCtD
Rabeprazole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	8.98e-05	0.00059	CcSEcCtD
Rabeprazole—Nausea—Tiotropium—chronic obstructive pulmonary disease	8.97e-05	0.000589	CcSEcCtD
Rabeprazole—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	8.95e-05	0.000588	CcSEcCtD
Rabeprazole—Dry skin—Prednisone—chronic obstructive pulmonary disease	8.95e-05	0.000588	CcSEcCtD
Rabeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.88e-05	0.00148	CbGpPWpGaD
Rabeprazole—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	8.88e-05	0.000583	CcSEcCtD
Rabeprazole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	8.8e-05	0.000578	CcSEcCtD
Rabeprazole—Asthenia—Formoterol—chronic obstructive pulmonary disease	8.75e-05	0.000574	CcSEcCtD
Rabeprazole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	8.75e-05	0.000574	CcSEcCtD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	8.67e-05	0.00145	CbGpPWpGaD
Rabeprazole—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.67e-05	0.00145	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	8.67e-05	0.00145	CbGpPWpGaD
Rabeprazole—Pruritus—Formoterol—chronic obstructive pulmonary disease	8.62e-05	0.000566	CcSEcCtD
Rabeprazole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	8.62e-05	0.000566	CcSEcCtD
Rabeprazole—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	8.61e-05	0.000565	CcSEcCtD
Rabeprazole—Asthenia—Montelukast—chronic obstructive pulmonary disease	8.57e-05	0.000563	CcSEcCtD
Rabeprazole—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	8.55e-05	0.00143	CbGpPWpGaD
Rabeprazole—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000558	CcSEcCtD
Rabeprazole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	8.48e-05	0.000557	CcSEcCtD
Rabeprazole—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	8.45e-05	0.00141	CbGpPWpGaD
Rabeprazole—Pruritus—Montelukast—chronic obstructive pulmonary disease	8.45e-05	0.000555	CcSEcCtD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.35e-05	0.00139	CbGpPWpGaD
Rabeprazole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	8.34e-05	0.000548	CcSEcCtD
Rabeprazole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	8.34e-05	0.000548	CcSEcCtD
Rabeprazole—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	8.3e-05	0.000545	CcSEcCtD
Rabeprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.28e-05	0.00138	CbGpPWpGaD
Rabeprazole—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	8.27e-05	0.000543	CcSEcCtD
Rabeprazole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	8.26e-05	0.000542	CcSEcCtD
Rabeprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.21e-05	0.00137	CbGpPWpGaD
Rabeprazole—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.17e-05	0.00136	CbGpPWpGaD
Rabeprazole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	8.17e-05	0.000537	CcSEcCtD
Rabeprazole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	8.14e-05	0.000535	CcSEcCtD
Rabeprazole—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	8.11e-05	0.00136	CbGpPWpGaD
Rabeprazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.1e-05	0.00135	CbGpPWpGaD
Rabeprazole—Erythema—Prednisolone—chronic obstructive pulmonary disease	8.09e-05	0.000531	CcSEcCtD
Rabeprazole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	8.06e-05	0.000529	CcSEcCtD
Rabeprazole—Dizziness—Formoterol—chronic obstructive pulmonary disease	8.06e-05	0.000529	CcSEcCtD
Rabeprazole—Dizziness—Montelukast—chronic obstructive pulmonary disease	7.9e-05	0.000519	CcSEcCtD
Rabeprazole—Neutropenia—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.000518	CcSEcCtD
Rabeprazole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	7.88e-05	0.000517	CcSEcCtD
Rabeprazole—CYP1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.84e-05	0.00131	CbGpPWpGaD
Rabeprazole—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	7.77e-05	0.00051	CcSEcCtD
Rabeprazole—CYP1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.75e-05	0.0013	CbGpPWpGaD
Rabeprazole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	7.75e-05	0.000509	CcSEcCtD
Rabeprazole—Vomiting—Formoterol—chronic obstructive pulmonary disease	7.75e-05	0.000509	CcSEcCtD
Rabeprazole—Rash—Formoterol—chronic obstructive pulmonary disease	7.69e-05	0.000505	CcSEcCtD
Rabeprazole—Rash—Arformoterol—chronic obstructive pulmonary disease	7.69e-05	0.000505	CcSEcCtD
Rabeprazole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	7.68e-05	0.000504	CcSEcCtD
Rabeprazole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	7.68e-05	0.000504	CcSEcCtD
Rabeprazole—Weight increased—Prednisone—chronic obstructive pulmonary disease	7.68e-05	0.000504	CcSEcCtD
Rabeprazole—Headache—Arformoterol—chronic obstructive pulmonary disease	7.64e-05	0.000502	CcSEcCtD
Rabeprazole—Headache—Formoterol—chronic obstructive pulmonary disease	7.64e-05	0.000502	CcSEcCtD
Rabeprazole—Weight decreased—Prednisone—chronic obstructive pulmonary disease	7.63e-05	0.000501	CcSEcCtD
Rabeprazole—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	7.62e-05	0.000501	CcSEcCtD
Rabeprazole—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.62e-05	0.00127	CbGpPWpGaD
Rabeprazole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	7.61e-05	0.0005	CcSEcCtD
Rabeprazole—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	7.61e-05	0.0005	CcSEcCtD
Rabeprazole—Vomiting—Montelukast—chronic obstructive pulmonary disease	7.59e-05	0.000499	CcSEcCtD
Rabeprazole—Rash—Montelukast—chronic obstructive pulmonary disease	7.53e-05	0.000495	CcSEcCtD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	7.53e-05	0.00126	CbGpPWpGaD
Rabeprazole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	7.52e-05	0.000494	CcSEcCtD
Rabeprazole—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	7.51e-05	0.000493	CcSEcCtD
Rabeprazole—Headache—Montelukast—chronic obstructive pulmonary disease	7.48e-05	0.000491	CcSEcCtD
Rabeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.45e-05	0.00124	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.44e-05	0.00124	CbGpPWpGaD
Rabeprazole—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	7.41e-05	0.000487	CcSEcCtD
Rabeprazole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	7.39e-05	0.000486	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	7.37e-05	0.000484	CcSEcCtD
Rabeprazole—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	7.37e-05	0.000484	CcSEcCtD
Rabeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.35e-05	0.00123	CbGpPWpGaD
Rabeprazole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	7.32e-05	0.000481	CcSEcCtD
Rabeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.3e-05	0.00122	CbGpPWpGaD
Rabeprazole—Malaise—Prednisolone—chronic obstructive pulmonary disease	7.29e-05	0.000479	CcSEcCtD
Rabeprazole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	7.27e-05	0.000477	CcSEcCtD
Rabeprazole—Rash—Salbutamol—chronic obstructive pulmonary disease	7.26e-05	0.000477	CcSEcCtD
Rabeprazole—Syncope—Prednisolone—chronic obstructive pulmonary disease	7.25e-05	0.000476	CcSEcCtD
Rabeprazole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	7.25e-05	0.000476	CcSEcCtD
Rabeprazole—Nausea—Arformoterol—chronic obstructive pulmonary disease	7.24e-05	0.000476	CcSEcCtD
Rabeprazole—Nausea—Formoterol—chronic obstructive pulmonary disease	7.24e-05	0.000476	CcSEcCtD
Rabeprazole—Headache—Salbutamol—chronic obstructive pulmonary disease	7.21e-05	0.000474	CcSEcCtD
Rabeprazole—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	7.11e-05	0.000467	CcSEcCtD
Rabeprazole—Nausea—Montelukast—chronic obstructive pulmonary disease	7.09e-05	0.000466	CcSEcCtD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	7.05e-05	0.00118	CbGpPWpGaD
Rabeprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.01e-05	0.00117	CbGpPWpGaD
Rabeprazole—Convulsion—Prednisolone—chronic obstructive pulmonary disease	7.01e-05	0.00046	CcSEcCtD
Rabeprazole—Hypertension—Prednisolone—chronic obstructive pulmonary disease	6.98e-05	0.000459	CcSEcCtD
Rabeprazole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.92e-05	0.00116	CbGpPWpGaD
Rabeprazole—Bradycardia—Prednisone—chronic obstructive pulmonary disease	6.87e-05	0.000452	CcSEcCtD
Rabeprazole—Nausea—Salbutamol—chronic obstructive pulmonary disease	6.84e-05	0.000449	CcSEcCtD
Rabeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	6.82e-05	0.00114	CbGpPWpGaD
Rabeprazole—Discomfort—Prednisolone—chronic obstructive pulmonary disease	6.8e-05	0.000447	CcSEcCtD
Rabeprazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.71e-05	0.00112	CbGpPWpGaD
Rabeprazole—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	6.69e-05	0.00112	CbGpPWpGaD
Rabeprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.65e-05	0.00111	CbGpPWpGaD
Rabeprazole—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	6.6e-05	0.000434	CcSEcCtD
Rabeprazole—Oedema—Prednisolone—chronic obstructive pulmonary disease	6.6e-05	0.000434	CcSEcCtD
Rabeprazole—CYP1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.52e-05	0.00109	CbGpPWpGaD
Rabeprazole—Shock—Prednisolone—chronic obstructive pulmonary disease	6.5e-05	0.000427	CcSEcCtD
Rabeprazole—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	6.44e-05	0.000423	CcSEcCtD
Rabeprazole—CYP1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.43e-05	0.00107	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.42e-05	0.00107	CbGpPWpGaD
Rabeprazole—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	6.38e-05	0.000419	CcSEcCtD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	6.37e-05	0.00106	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.35e-05	0.00106	CbGpPWpGaD
Rabeprazole—Eye disorder—Prednisone—chronic obstructive pulmonary disease	6.31e-05	0.000414	CcSEcCtD
Rabeprazole—Angiopathy—Prednisone—chronic obstructive pulmonary disease	6.13e-05	0.000402	CcSEcCtD
Rabeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.04e-05	0.00101	CbGpPWpGaD
Rabeprazole—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	6.03e-05	0.000396	CcSEcCtD
Rabeprazole—Insomnia—Prednisolone—chronic obstructive pulmonary disease	5.97e-05	0.000392	CcSEcCtD
Rabeprazole—Alopecia—Prednisone—chronic obstructive pulmonary disease	5.97e-05	0.000392	CcSEcCtD
Rabeprazole—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	5.93e-05	0.000389	CcSEcCtD
Rabeprazole—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	5.93e-05	0.00099	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.9e-05	0.000986	CbGpPWpGaD
Rabeprazole—Erythema—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000386	CcSEcCtD
Rabeprazole—Malnutrition—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000386	CcSEcCtD
Rabeprazole—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.85e-05	0.000978	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	5.85e-05	0.000977	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.84e-05	0.000975	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.79e-05	0.000966	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	5.74e-05	0.000958	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	5.74e-05	0.000958	CbGpPWpGaD
Rabeprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.69e-05	0.00095	CbGpPWpGaD
Rabeprazole—Pain—Prednisolone—chronic obstructive pulmonary disease	5.65e-05	0.000371	CcSEcCtD
Rabeprazole—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	5.63e-05	0.00094	CbGpPWpGaD
Rabeprazole—Vision blurred—Prednisone—chronic obstructive pulmonary disease	5.54e-05	0.000364	CcSEcCtD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.51e-05	0.000921	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	5.46e-05	0.000912	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.46e-05	0.000912	CbGpPWpGaD
Rabeprazole—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	5.45e-05	0.000358	CcSEcCtD
Rabeprazole—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	5.45e-05	0.00091	CbGpPWpGaD
Rabeprazole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	5.44e-05	0.000357	CcSEcCtD
Rabeprazole—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.44e-05	0.000908	CbGpPWpGaD
Rabeprazole—Anaemia—Prednisone—chronic obstructive pulmonary disease	5.43e-05	0.000357	CcSEcCtD
Rabeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.41e-05	0.000904	CbGpPWpGaD
Rabeprazole—Agitation—Prednisone—chronic obstructive pulmonary disease	5.4e-05	0.000355	CcSEcCtD
Rabeprazole—Angioedema—Prednisone—chronic obstructive pulmonary disease	5.37e-05	0.000353	CcSEcCtD
Rabeprazole—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.36e-05	0.000896	CbGpPWpGaD
Rabeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.34e-05	0.000892	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.33e-05	0.000891	CbGpPWpGaD
Rabeprazole—Malaise—Prednisone—chronic obstructive pulmonary disease	5.3e-05	0.000348	CcSEcCtD
Rabeprazole—Vertigo—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.000347	CcSEcCtD
Rabeprazole—Syncope—Prednisone—chronic obstructive pulmonary disease	5.27e-05	0.000346	CcSEcCtD
Rabeprazole—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.26e-05	0.000879	CbGpPWpGaD
Rabeprazole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.24e-05	0.000344	CcSEcCtD
Rabeprazole—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	5.17e-05	0.000339	CcSEcCtD
Rabeprazole—Convulsion—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000335	CcSEcCtD
Rabeprazole—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.07e-05	0.000333	CcSEcCtD
Rabeprazole—Myalgia—Prednisone—chronic obstructive pulmonary disease	5e-05	0.000329	CcSEcCtD
Rabeprazole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	5e-05	0.000329	CcSEcCtD
Rabeprazole—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5e-05	0.000836	CbGpPWpGaD
Rabeprazole—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5e-05	0.000835	CbGpPWpGaD
Rabeprazole—Anxiety—Prednisone—chronic obstructive pulmonary disease	4.99e-05	0.000328	CcSEcCtD
Rabeprazole—Discomfort—Prednisone—chronic obstructive pulmonary disease	4.94e-05	0.000325	CcSEcCtD
Rabeprazole—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.94e-05	0.000826	CbGpPWpGaD
Rabeprazole—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.93e-05	0.000823	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.91e-05	0.00082	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.86e-05	0.000813	CbGpPWpGaD
Rabeprazole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.86e-05	0.000319	CcSEcCtD
Rabeprazole—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.84e-05	0.000808	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	4.8e-05	0.000802	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.8e-05	0.000801	CbGpPWpGaD
Rabeprazole—Oedema—Prednisone—chronic obstructive pulmonary disease	4.8e-05	0.000315	CcSEcCtD
Rabeprazole—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	4.8e-05	0.000315	CcSEcCtD
Rabeprazole—Shock—Prednisone—chronic obstructive pulmonary disease	4.72e-05	0.00031	CcSEcCtD
Rabeprazole—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.68e-05	0.000308	CcSEcCtD
Rabeprazole—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.64e-05	0.000305	CcSEcCtD
Rabeprazole—Anorexia—Prednisone—chronic obstructive pulmonary disease	4.57e-05	0.0003	CcSEcCtD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.51e-05	0.000754	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.45e-05	0.000743	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.39e-05	0.000733	CbGpPWpGaD
Rabeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.39e-05	0.000733	CbGpPWpGaD
Rabeprazole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.37e-05	0.000287	CcSEcCtD
Rabeprazole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.37e-05	0.000287	CcSEcCtD
Rabeprazole—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.34e-05	0.000285	CcSEcCtD
Rabeprazole—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.31e-05	0.000283	CcSEcCtD
Rabeprazole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.22e-05	0.000277	CcSEcCtD
Rabeprazole—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.17e-05	0.000274	CcSEcCtD
Rabeprazole—Rash—Prednisolone—chronic obstructive pulmonary disease	4.16e-05	0.000273	CcSEcCtD
Rabeprazole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.16e-05	0.000273	CcSEcCtD
Rabeprazole—Headache—Prednisolone—chronic obstructive pulmonary disease	4.14e-05	0.000272	CcSEcCtD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.11e-05	0.000687	CbGpPWpGaD
Rabeprazole—Constipation—Prednisone—chronic obstructive pulmonary disease	4.1e-05	0.000269	CcSEcCtD
Rabeprazole—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.09e-05	0.000684	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.09e-05	0.000683	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.06e-05	0.000679	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.06e-05	0.000678	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.04e-05	0.000674	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.03e-05	0.000674	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4e-05	0.000668	CbGpPWpGaD
Rabeprazole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.95e-05	0.00026	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	3.92e-05	0.000258	CcSEcCtD
Rabeprazole—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.92e-05	0.000258	CcSEcCtD
Rabeprazole—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.88e-05	0.000647	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.86e-05	0.000645	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.82e-05	0.000639	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.82e-05	0.000637	CbGpPWpGaD
Rabeprazole—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.81e-05	0.00025	CcSEcCtD
Rabeprazole—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	3.81e-05	0.000637	CbGpPWpGaD
Rabeprazole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.79e-05	0.000249	CcSEcCtD
Rabeprazole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.79e-05	0.000249	CcSEcCtD
Rabeprazole—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.76e-05	0.000628	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	3.73e-05	0.000623	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.73e-05	0.000623	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.73e-05	0.000623	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.71e-05	0.00062	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.68e-05	0.000614	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	3.66e-05	0.000611	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	3.66e-05	0.000611	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	3.63e-05	0.000606	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.57e-05	0.000596	CbGpPWpGaD
Rabeprazole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.53e-05	0.000232	CcSEcCtD
Rabeprazole—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.53e-05	0.00059	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.52e-05	0.000587	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.52e-05	0.000587	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.49e-05	0.000582	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.48e-05	0.000582	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.48e-05	0.000582	CbGpPWpGaD
Rabeprazole—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.47e-05	0.000579	CbGpPWpGaD
Rabeprazole—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.44e-05	0.000226	CcSEcCtD
Rabeprazole—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.42e-05	0.000571	CbGpPWpGaD
Rabeprazole—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.39e-05	0.000223	CcSEcCtD
Rabeprazole—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.37e-05	0.000563	CbGpPWpGaD
Rabeprazole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.28e-05	0.000216	CcSEcCtD
Rabeprazole—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.21e-05	0.000536	CbGpPWpGaD
Rabeprazole—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.19e-05	0.000532	CbGpPWpGaD
Rabeprazole—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.17e-05	0.000208	CcSEcCtD
Rabeprazole—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.16e-05	0.000529	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.14e-05	0.000525	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.12e-05	0.000521	CbGpPWpGaD
Rabeprazole—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.05e-05	0.0002	CcSEcCtD
Rabeprazole—Rash—Prednisone—chronic obstructive pulmonary disease	3.02e-05	0.000199	CcSEcCtD
Rabeprazole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.02e-05	0.000199	CcSEcCtD
Rabeprazole—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.02e-05	0.000505	CbGpPWpGaD
Rabeprazole—Headache—Prednisone—chronic obstructive pulmonary disease	3.01e-05	0.000197	CcSEcCtD
Rabeprazole—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.98e-05	0.000498	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.89e-05	0.000483	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.87e-05	0.000479	CbGpPWpGaD
Rabeprazole—Nausea—Prednisone—chronic obstructive pulmonary disease	2.85e-05	0.000187	CcSEcCtD
Rabeprazole—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.84e-05	0.000475	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.72e-05	0.000454	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.68e-05	0.000447	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.64e-05	0.000441	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.52e-05	0.000422	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.5e-05	0.000418	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.46e-05	0.000411	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	2.46e-05	0.00041	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.43e-05	0.000406	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.43e-05	0.000405	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.33e-05	0.000389	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.3e-05	0.000384	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.28e-05	0.000381	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.22e-05	0.000371	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.07e-05	0.000345	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.05e-05	0.000342	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.03e-05	0.000339	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.01e-05	0.000336	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.98e-05	0.000331	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.96e-05	0.000327	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.9e-05	0.000317	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.88e-05	0.000315	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.88e-05	0.000313	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.87e-05	0.000312	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.87e-05	0.000312	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.85e-05	0.000309	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.83e-05	0.000306	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.79e-05	0.000299	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.74e-05	0.00029	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.73e-05	0.000289	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.72e-05	0.000287	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.7e-05	0.000285	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.65e-05	0.000275	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.61e-05	0.000269	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.57e-05	0.000262	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.49e-05	0.000249	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.46e-05	0.000243	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.37e-05	0.000229	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.36e-05	0.000227	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.35e-05	0.000226	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.34e-05	0.000224	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.33e-05	0.000222	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.26e-05	0.000211	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.24e-05	0.000208	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.24e-05	0.000207	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.21e-05	0.000202	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.21e-05	0.000202	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	0.0002	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000194	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.12e-05	0.000188	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.11e-05	0.000186	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.1e-05	0.000183	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.09e-05	0.000181	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.01e-05	0.000169	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.01e-05	0.000169	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1e-05	0.000167	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.98e-06	0.000167	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.9e-06	0.000165	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.89e-06	0.000165	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.3e-06	0.000155	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.23e-06	0.000154	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.17e-06	0.000153	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.12e-06	0.000152	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.11e-06	0.000152	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	9.03e-06	0.000151	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.55e-06	0.000143	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.54e-06	0.000143	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	8.46e-06	0.000141	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.39e-06	0.00014	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.32e-06	0.000139	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	8.13e-06	0.000136	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.88e-06	0.000132	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.78e-06	0.00013	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	7.72e-06	0.000129	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.61e-06	0.000127	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.5e-06	0.000125	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7e-06	0.000117	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.99e-06	0.000117	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.94e-06	0.000116	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.9e-06	0.000115	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.84e-06	0.000114	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.63e-06	0.000111	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.6e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.53e-06	0.000109	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.43e-06	0.000107	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.38e-06	0.000107	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.1e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.04e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.95e-06	9.95e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.93e-06	9.9e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.85e-06	9.77e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	5.51e-06	9.2e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.49e-06	9.16e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.45e-06	9.1e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.27e-06	8.8e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.17e-06	8.63e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.58e-06	7.64e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.51e-06	7.54e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.51e-06	7.53e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.31e-06	7.2e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.2e-06	7.02e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.14e-06	6.92e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.11e-06	6.86e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.99e-06	6.66e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.96e-06	6.62e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.93e-06	6.56e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.51e-06	5.86e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.36e-06	5.61e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.71e-06	4.53e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.59e-06	4.33e-05	CbGpPWpGaD
